Research institutionUnited Statesuofmhealth.org
University of Michigan Health, the patient care division of Michigan Medicine at the University of Michigan, operates as a major academic medical center providing comprehensive hospital, outpatient, specialty, and emergency services. It manages a network of facilities including University Hospital, C.S. Mott Children’s Hospital, Von Voigtlander Women’s Hospital, and the Frankel Cardiovascular Center, along with regional partners such as UM Health-Sparrow and UM Health-West across Michigan.
The organization delivers care in numerous specialties including pulmonology and lung surgery, cardiology, oncology, neurology, and ophthalmology, with over 1,100 licensed beds and millions of annual outpatient visits. It participates actively in clinical research and trials, including respiratory disease studies such as the Phase 3 AIRWARD trial for COPD led by its faculty. As part of a public research university, it integrates patient care with medical education through the U-M Medical School and supports substantial biomedical research efforts.
Governed within the University of Michigan structure, University of Michigan Health emphasizes accessible, high-quality care statewide and ranks as Michigan’s top hospital and among the nation’s elite academic medical centers according to U.S. News & World Report evaluations.
Also known as UM Health and University of Michigan Health System.
None yet. When a new project in the record names U-M Health as owner, partner or investor, it shows here.
Randomized, placebo-controlled Phase III will enroll ~1,800 symptomatic COPD adults (≥40) with blood eosinophils <300 cells/µL to test exacerbation reduction over 52–76 weeks.
